Abstract
Squamous cell carcinoma of the bronchus still appears to be one of the most lethal of all malignancies. Under actual therapeutic conditions cure can be anticipated only when complete surgical resection is possible. Bronchogenic carcinoma responds poorly to chemotherapy [2, 5, 10] and in some trials no beneficial effect of systematic application of a “preventive” chemotherapy protocol after surgery was found [1]. Radiotherapy appears generally ineffective [3, 9], but recent results have demonstrated that it can increase the median survival when applied after surgery in patients with lymph node involvement.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Reference
Brunner, K. W., Marthaler, T. H., Muller, W.: Unfavorable effects of long terme adjuvant chemotherapy with endoxan in radically operated bronchogenic carcinoma. Eur. J. Cancer 7, 285 (1971).
Edmonson, E. J., Lagalos, St., Stolbach, L., Perlia, Ch. P., Bennett, J. M., Mansour, E. G., Horton, J., Regelson, W., Commings, F. J., Israel, L., Brodsky, I., Smider, B. T., Creech, R., Carbone, P. P.: Mechlorethamine (NSC 762) plus CCNU (NSC 79037) in the treatment of inoperable squamous and large cell carcinoma of the lung. Cancer Treat. Rep. 60, 625–627 (1976).
Hansen, H. H., Muggia, F. M., Andrews, R., Selawry, O. S.: Intensive combined chemotherapy and radiotherapy in patients with non resectable bronchogenic carcinoma. Cancer 30, 315–324 (1972).
Israel, L., Mugica, J., Chahinian, P.: Prognosis of early bronchogenic carcinoma. Survival curves of 451 patients after resection of lung cancer in relation to the results of pre-operative tuberculin skin tests. Biomedicine 19, 68–72 (1973).
Linvingston, R. B., Fee, W. H., Einhorn, L. H., Burgess, M. A., Freireich, E. J., Gottlieb, J. A., Farber, M. O.: B.A.C.O.N. (bleomycin, adriamycin, CCNU, oncovin and nitrogen-mustard) in squamous lung cancer. Experience in fifty patients. Cancer 37, 1237–1242 (1976).
Mathé, G., Pouillart, P., Lapeyraque, F.: Active immunotherapy of L1210 leukemia applied after the graft of tumor cell. Br. J. Cancer 23, 814 (1969).
Pouillart, P., Botto, G., Gautier, H., Huguenin, P., Baron, A., Laparre, C., Hoang Thi, H. T., Parrot, R., Mathé, L. G.: Relation entre l’état immunitaire et la réponse à la chimiothérapie. Résultats chez 64 malades avec cancers bronchiques épidermoïdes inopérables. Nouv. Presse Méd. 5, 1037 (1976).
Pouillart, P., Palangie, T., Huguenin, P., Morin, P., Gautier, H., Baron, A., Mathé, G., Lededente, A., Botto, G.: Cancers épidermoïdes bronchiques inopérables. Etude de la signification pronostique de l’état immunitaire et résultats d’un essai d’immunorestauration par le B.C.G. Nouv. Presse Méd. 7, 265–269 (1978).
Roswitt, B., Patno, M. E., Rapp, R., Veinberg, A., Feder, B., Stuhlbarg, J., Reid, C. B.: The survival of patients with inoperable lung cancer: large scale randomized study of radiation therapy versus placebo. Radiology 90, 668–671 (1968).
Vincent, R. G., Pickren, J. W., Fergen, T. B., Takita, H.: Evaluation of methotrexate in the treatment of bronchogenic carcinoma. Cancer 36, 873–880 (1975).
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1979 Springer-Verlag Berlin · Heidelberg
About this chapter
Cite this chapter
Pouillart, P. et al. (1979). Attempt at Immunotherapy With Living BCG in Patients With Bronchus Carcinoma. In: Bonadonna, G., Mathé, G., Salmon, S.E. (eds) Adjuvant Therapies and Markers of Post-Surgical Minimal Residual Disease II. Recent Results in Cancer Research, vol 68. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-81332-0_41
Download citation
DOI: https://doi.org/10.1007/978-3-642-81332-0_41
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-81334-4
Online ISBN: 978-3-642-81332-0
eBook Packages: Springer Book Archive